A detailed history of Ferguson Wellman Capital Management, Inc transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Ferguson Wellman Capital Management, Inc holds 26,974 shares of EW stock, worth $2.02 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
26,974
Previous 26,959 0.06%
Holding current value
$2.02 Million
Previous $1.78 Million 0.06%
% of portfolio
0.04%
Previous 0.04%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$59.7 - $93.78 $895 - $1,406
15 Added 0.06%
26,974 $1.78 Million
Q3 2024

Oct 18, 2024

SELL
$59.7 - $93.78 $72,535 - $113,942
-1,215 Reduced 4.31%
26,959 $1.78 Million
Q2 2024

Jul 16, 2024

SELL
$84.3 - $94.31 $12,645 - $14,146
-150 Reduced 0.53%
28,174 $2.6 Million
Q1 2024

Apr 09, 2024

SELL
$72.54 - $95.56 $3,627 - $4,778
-50 Reduced 0.18%
28,324 $2.71 Million
Q3 2023

Oct 12, 2023

SELL
$69.28 - $93.38 $10,738 - $14,473
-155 Reduced 0.54%
28,374 $1.97 Million
Q2 2023

Jul 11, 2023

BUY
$81.41 - $94.33 $6,838 - $7,923
84 Added 0.3%
28,529 $2.69 Million
Q1 2023

Apr 20, 2023

SELL
$74.26 - $84.51 $4,529 - $5,155
-61 Reduced 0.21%
28,445 $2.35 Million
Q3 2022

Oct 17, 2022

SELL
$82.37 - $107.29 $33,689 - $43,881
-409 Reduced 1.41%
28,506 $2.36 Million
Q2 2022

Jul 14, 2022

SELL
$86.5 - $128.27 $5,276 - $7,824
-61 Reduced 0.21%
28,915 $2.75 Million
Q1 2022

Apr 14, 2022

BUY
$101.96 - $128.34 $8,360 - $10,523
82 Added 0.28%
28,976 $3.41 Million
Q4 2021

Jan 10, 2022

SELL
$106.37 - $130.68 $41,803 - $51,357
-393 Reduced 1.34%
28,894 $3.74 Million
Q2 2021

Jul 12, 2021

SELL
$83.84 - $104.76 $1,089 - $1,361
-13 Reduced 0.04%
29,287 $3.03 Million
Q4 2020

Feb 04, 2021

SELL
$71.69 - $91.23 $65,237 - $83,019
-910 Reduced 3.01%
29,300 $2.67 Million
Q2 2020

Aug 04, 2020

BUY
$57.54 - $76.95 $1.15 Million - $1.54 Million
20,048 Added 197.28%
30,210 $2.09 Million
Q4 2019

Jan 24, 2020

SELL
$71.7 - $82.09 $717 - $820
-10 Reduced 0.1%
10,162 $2.37 Million
Q2 2019

Jul 16, 2019

SELL
$55.74 - $64.41 $12,207 - $14,105
-219 Reduced 2.11%
10,172 $1.88 Million
Q3 2018

Oct 25, 2018

SELL
$45.7 - $58.03 $5,484 - $6,963
-120 Reduced 1.14%
10,391 $1.81 Million
Q2 2018

Aug 10, 2018

SELL
$42.45 - $51.3 $2,122 - $2,565
-50 Reduced 0.47%
10,511 $1.53 Million
Q1 2018

Apr 09, 2018

BUY
$37.19 - $47.45 $7,512 - $9,584
202 Added 1.95%
10,561 $1.47 Million
Q4 2017

Jan 24, 2018

BUY
$33.79 - $39.39 $4,899 - $5,711
145 Added 1.42%
10,359 $1.17 Million
Q3 2017

Oct 11, 2017

BUY
$36.29 - $38.83 $370,666 - $396,609
10,214
10,214 $1.12 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $46.3B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Ferguson Wellman Capital Management, Inc Portfolio

Follow Ferguson Wellman Capital Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ferguson Wellman Capital Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ferguson Wellman Capital Management, Inc with notifications on news.